Medicaid insurance policies fluctuate from state-to-state. With the appearance of recent, GLP-1 drugs (and others) to deal with weight problems and chubby, there are probably important well being advantages to be gained. Nevertheless, are State Medicaid Companies really masking these drugs? That is the query requested by Liu et al. (2024). They use knowledge from public state Medicaid formulary and most popular drug listing information to find out if a state lined FDA-approved anti-obesity drugs. The variety of reimbursed prescriptions for every antiobesity remedy was recognized from public 2011-2022 Medicaid State Drug Utilization knowledge.

Normally, some however not all anti-obesity drugs are lined. Furthermore, the more practical GLP-1 drugs are usually solely lined if they’re used to deal with diabetes (reasonably than chubby or weight problems).

Within the first quarter of 2023, 10 of 47 states (21%) with public most popular drug lists lined not less than 1 antiobesity remedy; 5 (11%) had unrestricted protection of not less than 1 antiobesity remedy…Individually, 39 states (83%) had unrestricted protection of not less than 1 of the two diabetes variations of GLP-1 RAs.

The complete article is right here.